ARCHIVES

DCPC Advisors Approve Five New RFA concepts, Set Aside $33.6 Million

This article is from The Cancer Letter archive.

Vol. 19 No. 23 | June 4, 1993

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group, Cancer Center Trials Listed

March 27, 2009

Also David Schwartz of Duke University to head NIEHS.

October 29, 2004

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

May 13, 2005

Sunitinib Prolongs Survival In Poor Prognosis, Study Finds

July 31, 2009

Appropriations: NIH Professional Needs Budget Gains Attention

March 14, 1997

Amgen Pays $24.9 Million To Settle Kickback Charges

April 19, 2013